TSS
WHWK

Two Sigma Securities’s Whitehawk Therapeutics WHWK Stock Holding History

Two Sigma Securities’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,103
Closed -$20.8K – 2140
2025
Q2 		$20.8K Buy
+11,103
New +$19.3K ﹤0.01% 1203
2020
Q3 		– Sell
-1,645
Closed -$31K – 1713
2020
Q2 		$31K Buy
+1,645
New +$21.5K ﹤0.01% 1277
2019
Q2 		– Sell
-800
Closed -$11K – 2493
2019
Q1 		$11K Buy
+800
New +$34.4K ﹤0.01% 1727

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

Two Sigma Securities's WHWK Position: Q3 2025 in Review

Two Sigma Securities sold out of Whitehawk Therapeutics (WHWK) in Q3 2025, closing a stake of 11,103 shares — an estimated $20.8K sold.

Two Sigma Securities first reported a position in WHWK in Q1 2019 and held it in 3 quarters. The position peaked at $31K in Q2 2020. 41 funds tracked by Wall St. Rank hold WHWK as of Q3 2025.

  • Two Sigma Securities reported no remaining Whitehawk Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Securities sold 11,103 Whitehawk Therapeutics shares in Q3 2025, an estimated $20.8K.
  • Two Sigma Securities first reported a position in Whitehawk Therapeutics in Q1 2019 and held it in 3 quarters.
  • Two Sigma Securities's Whitehawk Therapeutics position peaked at $31K in Q2 2020.
  • 41 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.